Australia on the rise for outsourcing; Therapure Biopharma completes new wing;

> Irish CRO ICON enjoyed a 10% increase in Q1 revenue, according to the Irish Times. Story

> INC Research hopes to expand its infectious disease team with the appointment of Frederick Young as its VP. Release

> Therapure Biopharma, a Canadian CDMO, recently completed work on its custom biologics manufacturing wing at its Toronto facility, according to Outsourcing-Pharma. Article

> Representatives from pharma sponsors and CROs will gather in New Brunswick, NJ, from May 1 to May 2, for a quality summit hosted by the Avoca Group. News

> FierceDrugDelivery looks at why Australia is a rising star for outsourcing work. Analysis

Suggested Articles

Getting the right patients into the right trial at the right time, and keeping them there, is a tough gig.

The coronavirus is now putting a strain on CROs and researchers in affected areas.

Synteract has boosted its reach into the Asia-Pacific region and South Africa after snapping up a specialty biometrics CRO.